Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
A high-yield ETF draws retiree interest, but Warren Buffett would never chase yields at the expense of long-term grow...
Investors chase steady cash flow as Nasdaq exposure persists. The Invesco QQQ Income Advantage ETF delivers monthly p...
Analysts sometimes cut targets right before a big earnings release. This piece explains why that timing can mislead i...
Learning to find high-cash-flow vacation rentals isn’t about luck. This guide shows a loan-friendly approach using pr...
When jelly roll’s daughter says there’s more to the story, the internet roars. This article explores the money side o...
Trump rejects Kurdish involvement in Iran war, triggering cautious moves in oil, equities, and currencies as markets ...
Ten years after the Brexit vote, Britain faces political churn and stubborn economic headwinds. Seven prime ministers...
As Treasury yields rise, SPHD's monthly distributions remain a focal point for income investors. This dividend safety...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
When a metropolitan bank director sells shares, it catches the eye of investors. This article explains insider filing...
When a Tanger director cashed $518,000, investors take notice. This article breaks down insider trades, what signals ...